Infliximab Tx Effects Dramatic in Psoriasis and Psoriatic Arthritis

Chicago - Results of two multicenter, double-blind, placebo-controlled trials support the conclusion that the TNF-a chimeric monoclonal antibody infliximab (Remicade) is a highly effective and generally well-tolerated treatment for psoriasis and psoriatic arthritis, Alan D. Menter, M.D., said.

Related Videos
Related Content

Highlights from AAD 2023

March 23rd 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

New Technology Could Allow Us to Rethink Alopecia Scores

March 23rd 2023

The Cutaneous Connection- Episode 35: QRPs and the Dermatology Practice

December 2nd 2021

Pregnant Women with Skin Conditions May Require Dermatologic Intervention

March 23rd 2023

Frontline Forum Part 3: A Discussion of the Pathophysiology of Acne and Available Treatment Strategies

March 23rd 2023

Highlights from AAD 2023

March 23rd 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

New Technology Could Allow Us to Rethink Alopecia Scores

March 23rd 2023

The Cutaneous Connection- Episode 35: QRPs and the Dermatology Practice

December 2nd 2021

Pregnant Women with Skin Conditions May Require Dermatologic Intervention

March 23rd 2023

Frontline Forum Part 3: A Discussion of the Pathophysiology of Acne and Available Treatment Strategies

March 23rd 2023

Highlights from AAD 2023

March 23rd 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

New Technology Could Allow Us to Rethink Alopecia Scores

March 23rd 2023

The Cutaneous Connection- Episode 35: QRPs and the Dermatology Practice

December 2nd 2021

Pregnant Women with Skin Conditions May Require Dermatologic Intervention

March 23rd 2023

Frontline Forum Part 3: A Discussion of the Pathophysiology of Acne and Available Treatment Strategies

March 23rd 2023
© 2023 MJH Life Sciences

All rights reserved.